Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy
Published inMuscle & nerve, vol. 41, no. 2, p. 286-287
Publication date2010
Keywords
- Antineoplastic Agents, Alkylating/*therapeutic use
- Dose-Response Relationship, Drug
- Humans
- Male
- Melphalan/*therapeutic use
- Middle Aged
- Myopathies, Nemaline/*drug therapy
- Paraproteinemias/*drug therapy
- Treatment Outcome
Affiliation entities
Citation (ISO format)
NOVY, Jan et al. Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy. In: Muscle & nerve, 2010, vol. 41, n° 2, p. 286–287. doi: 10.1002/mus.21560
Main files (1)
Article
Identifiers
- PID : unige:21190
- DOI : 10.1002/mus.21560
- PMID : 19918772
Additional URL for this publicationhttp://onlinelibrary.wiley.com/store/10.1002/mus.21560/asset/21560_ftp.pdf?v=1&t=h1qhgy4u&s=5741f2790e6a08af574c72ea9a9535015b7df395
Journal ISSN0148-639X
